Transcriptional Control by myb Oncogene Product

Shunsuke Ishii, Teruaki Nomura, Chie Kanei-ishii, Hideki Nakagoshi, Tatsuhiko Sudo, Tetsuya Sawazaki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Structure and function of two domains of c-Myb were analyzed. We show that a leucine zipper structure is a component of the negative regulatory domain, because its disruption markedly increases both the transactivating and transforming capacities of c-Myb. Our results suggest that an inhibitor which suppresses transactivation binds to c-Myb through the leucine zipper, and that c-Myb can be oncogenically activated by mis-sense mutation. We also proposed a model, the “tryptophan cluster”, for the structure of the Myb DNA-binding domain, in which the three tryptophans form a cluster in the hydrophobic core in each repeat. The results of NMR analysis of repeat 3 revealed that the conserved tryptophans play a key role to make the hydrophobic core.

Original languageEnglish
Pages (from-to)189-194
Number of pages6
JournalTohoku Journal of Experimental Medicine
Volume168
Issue number2
DOIs
Publication statusPublished - Jan 1 1992
Externally publishedYes

Keywords

  • NMR
  • leucine zipper
  • negative regulatory domain
  • sequence-specific DNA-binding protein

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Transcriptional Control by myb Oncogene Product'. Together they form a unique fingerprint.

  • Cite this

    Ishii, S., Nomura, T., Kanei-ishii, C., Nakagoshi, H., Sudo, T., & Sawazaki, T. (1992). Transcriptional Control by myb Oncogene Product. Tohoku Journal of Experimental Medicine, 168(2), 189-194. https://doi.org/10.1620/tjem.168.189